Humana, Cost plus Drugs Explore Partnership to Lower Prescription Drug Costs
Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes Healthcare Summit Thursday, December 4th in New York wiht Humana chief executive officer Jim Rechtin (right) and Bruce Japsen, Forbes Senior healthcare contributor. Cuban and Rechtin disclosed that Humana and Cost Plus Drugs are discussing ways to partner to lower the cost of prescription drugs for U.S. employers.
Jamel Toppin
Humana, one of the nation’s largest health insurers for older adults, and Mark Cuban’s Cost Plus Drugs are discussing ways to partner to lower the cost of prescription drugs for U.S. employers.
The potential for such a partnership was disclosed Thursday at the annual Forbes Healthcare Summit by Humana chief executive officer Jim Rechtin and Cuban, the billionaire entrepreneur who co-founded Cost Plus Drugs. The two said they were working together while participating in a panel focused on improving the patient experience at the pharmacy.
The initial effort for Humana and Cost Plus Drugs will be in the area of direct-to-employer programs that bypass conventional pharmacy benefit management companies,Cuban said.
“We’re talking to CenterWell,” Cuban said.
Keep reading